T1	PROC 44 69	Tratamiento a largo plazo
#1	AnnotatorNotes T1	C0023977; long-term treatment; Health Care Activity
T2	CHEM 74 83	BI 655130
T3	DISO 101 117	colitis ulcerosa
#2	AnnotatorNotes T3	C0009324; Ulcerative Colitis; Disease or Syndrome
T4	PROC 156 202	Ensayo abierto y a largo plazo de la seguridad
T5	CHEM 223 232	BI 655130
T6	DISO 250 266	colitis ulcerosa
#3	AnnotatorNotes T6	C0009324; Ulcerative Colitis; Disease or Syndrome
T7	PHYS 1342 1357	post-menopausia
#4	AnnotatorNotes T7	C0206159; Postmenopause; Organism Function
T8	CHEM 332 341	BI 655130
T9	DISO 364 380	Colitis ulcerosa
#5	AnnotatorNotes T9	C0009324; Ulcerative Colitis; Disease or Syndrome
T10	PROC 464 500	Consentimiento informado por escrito
#6	AnnotatorNotes T10	C0811741; Obtain informed written consent; Health Care Activity
T11	PROC 726 749	métodos anticonceptivos
#7	AnnotatorNotes T11	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T12	PROC 956 979	métodos anticonceptivos
#8	AnnotatorNotes T12	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T13	DISO 1132 1139	estéril
#9	AnnotatorNotes T13	C0021359; Infertility; Pathologic Function | C0917730; Female sterility; Finding | C4074771; Sterility, Reproductive; Pathologic Function
T14	PROC 1156 1170	esterilización
#10	AnnotatorNotes T14	C0038288; Sexual sterilization; Therapeutic or Preventive Procedure
T15	PHYS 1081 1097	post-menopáusica
#11	AnnotatorNotes T15	C0206159; Postmenopause; Organism Function
T16	PROC 1194 1207	histerectomía
#12	AnnotatorNotes T16	C0020699; Hysterectomy; Therapeutic or Preventive Procedure
T17	PROC 1209 1233	salpingectomía bilateral
#13	AnnotatorNotes T17	C2243030; bilateral salpingectomy; Therapeutic or Preventive Procedure
T18	PROC 1236 1258	ooforectomía bilateral
#14	AnnotatorNotes T18	C0278321; Bilateral oophorectomy; Therapeutic or Preventive Procedure
T19	PROC 1263 1282	ligadura de trompas
#15	AnnotatorNotes T19	C0520483; Tubal Ligation; Therapeutic or Preventive Procedure
T20	PROC 1302 1316	esterilización
#16	AnnotatorNotes T20	C0038288; Sexual sterilization; Therapeutic or Preventive Procedure
T21	PROC 1465 1476	tratamiento
#17	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	PROC 1559 1583	continuar el tratamiento
#18	AnnotatorNotes T22	C2091305; continue current medication; Therapeutic or Preventive Procedure
T23	DISO 1644 1668	acontecimientos adversos
#19	AnnotatorNotes T23	C0877248; Adverse event; Pathologic Function
T24	PROC 1688 1699	tratamiento
#20	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	PROC 1723 1747	tratamiento de inducción
#21	AnnotatorNotes T25	C0857127; Induction procedure; Therapeutic or Preventive Procedure
T26	CHEM 1755 1762	fármaco
#22	AnnotatorNotes T26	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T27	PROC 207 218	tratamiento
#23	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	PROC 1837 1857	estudio de inducción
T29	Date 12 16	2018
T30	Date 56 69	a largo plazo
T31	LIVB 87 96	pacientes
#24	AnnotatorNotes T31	C0030705; Patients; Patient or Disabled Group
T32	Date 173 186	a largo plazo
T33	LIVB 236 245	pacientes
#25	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	LIVB 444 451	mujeres
#26	AnnotatorNotes T34	C0043210; Woman; Population Group
T35	Age 452 460	≥18 años
T36	LIVB 632 648	mujeres fértiles
#27	AnnotatorNotes T36	C4324275; Woman of childbearing potential; Population Group
T38	LIVB 655 662	hombres
#28	AnnotatorNotes T38	C0025266; Male population group; Population Group
T40	Frequency 847 853	al año
T41	LIVB 923 931	paciente
#29	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	LIVB 1019 1024	mujer
#30	AnnotatorNotes T42	C0043210; Woman; Population Group
T44	PHYS 1059 1068	menarquia
#31	AnnotatorNotes T44	C0025274; Menarche; Organism Function
T49	Neg_cue 1283 1285	NO
T51	Duration 1373 1381	12 meses
T52	Neg_cue 1382 1385	sin
T53	PHYS 1395 1407	menstruación
#32	AnnotatorNotes T53	C0025344; Menstruation; Organism Function
T56	LIVB 434 441	Varones
#33	AnnotatorNotes T56	C0025266; Male population group; Population Group
T37	LIVB 687 691	hijo
#34	AnnotatorNotes T37	C0037683; Son (person); Family Group
T57	PHYS 667 683	puedan engendrar
#35	AnnotatorNotes T57	C3831118; Childbearing Potential; Clinical Attribute
T39	PROC 1482 1488	visita
#36	AnnotatorNotes T39	C1512346; Patient Visit; Health Care Activity
T43	CONC 1492 1505	fin de ensayo
#37	AnnotatorNotes T43	C4283764; Trial participation end date; Temporal Concept
A4	Assertion T20 Negated
A5	Assertion T53 Negated
A2	Status T23 History_of
#38	AnnotatorNotes T30	C0443252; Long-term; Temporal Concept
#39	AnnotatorNotes T32	C0443252; Long-term; Temporal Concept
#40	AnnotatorNotes T2	C5543835; BI 655130; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor 
#41	AnnotatorNotes T8	C5543835; BI 655130; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor 
#42	AnnotatorNotes T5	C5543835; BI 655130; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor 
T45	Neg_cue 1408 1411	sin
T46	Observation 1416 1428	causa médica
A3	Assertion T46 Negated
#44	AnnotatorNotes T46	C4745084; Medical Condition; Finding (?)
T47	Quantifier_or_Qualifier 1038 1044	fértil
R1	Negation Arg1:T49 Arg2:T20	
T48	Quantifier_or_Qualifier 1317 1327	permanente
A6	Assertion T48 Negated
#45	AnnotatorNotes T48	C0205355; Permanent; Temporal Concept
R2	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T48	
R3	Negation Arg1:T52 Arg2:T53	
R4	Negation Arg1:T45 Arg2:T46	
R5	Used_for Arg1:T2 Arg2:T1	
R6	Overlap Arg1:T2 Arg2:T30	
R7	Experiences Arg1:T31 Arg2:T1	
R8	Experiences Arg1:T31 Arg2:T3	
T50	Quantifier_or_Qualifier 118 134	moderada o grave
#46	AnnotatorNotes T50	C1299393; Moderate to severe; Qualitative Concept
R9	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T50	
R11	Overlap Arg1:T4 Arg2:T32	
R12	Used_for Arg1:T5 Arg2:T27	
R13	Experiences Arg1:T33 Arg2:T27	
R14	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T6	
T59	Quantifier_or_Qualifier 388 404	moderada o grave
#50	AnnotatorNotes T59	C1299393; Moderate to severe; Qualitative Concept
T60	Quantifier_or_Qualifier 274 290	moderada o grave
#51	AnnotatorNotes T60	C1299393; Moderate to severe; Qualitative Concept
R15	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T60	
R17	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T59	
T61	Observation 299 317	finalizado ensayos
#52	AnnotatorNotes T61	C2732579; Completion of clinical trial; Finding
T62	Quantifier_or_Qualifier 381 387	activa
#53	AnnotatorNotes T62	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R19	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T62	
T63	Quantifier_or_Qualifier 267 273	activa
#54	AnnotatorNotes T63	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R20	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T63	
R21	Has_Age Arg1:T56 Arg2:T35	
R22	Has_Age Arg1:T34 Arg2:T35	
T64	CONC 560 563	GCP
#55	AnnotatorNotes T64	C5235445; GCP Adherence Statement; Intellectual Product
T65	CONC 601 610	inclusión
#56	AnnotatorNotes T65	C1512693; Inclusion; Qualitative Concept
R23	Before Arg1:T10 Arg2:T65	
R24	Experiences Arg1:T38 Arg2:T57	
R25	Experiences Arg1:T36 Arg2:T57	
R26	Experiences Arg1:T36 Arg2:T11	
R27	Experiences Arg1:T38 Arg2:T11	
T66	Observation 704 714	dispuestos
#57	AnnotatorNotes T66	C0600109; Willing; Finding
R28	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T66	
R29	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T66	
T67	Quantifier_or_Qualifier 753 769	elevada eficacia
R30	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T67	
T68	CONC 776 779	ICH
#58	AnnotatorNotes T68	C4684685; ICH Common Technical Document; Intellectual Product
T69	CONC 818 831	tasa de fallo
T70	Result_or_Value 835 846	menos de 1%
R31	Has_Result_or_Value Arg1:T69 Arg2:T70	
R32	Has_Frequency Arg1:T69 Arg2:T40	
R33	Experiences Arg1:T41 Arg2:T12	
R34	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T47	
R35	After Arg1:T47 Arg2:T44	
R36	Before Arg1:T47 Arg2:T15	
R37	Experiences Arg1:T42 Arg2:T13	
T71	Quantifier_or_Qualifier 1171 1181	permanente
#59	AnnotatorNotes T71	C0205355; Permanent; Temporal Concept
R38	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T71	
R39	After Arg1:T7 Arg2:T51	
R40	Before Arg1:T53 Arg2:T7	
R41	Overlap Arg1:T53 Arg2:T46	
R42	Has_Duration_or_Interval Arg1:T53 Arg2:T51	
T72	Observation 1451 1476	finalizado el tratamiento
R43	Overlap Arg1:T39 Arg2:T43	
#60	AnnotatorNotes T72	C0580352; Treatment completed; Finding
T73	Quantifier_or_Qualifier 1451 1461	finalizado
#61	AnnotatorNotes T73	C1272693; Ended - status; Qualitative Concept
R44	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T73	
T74	Observation 1536 1545	dispuesto
#62	AnnotatorNotes T74	C0600109; Willing; Finding
T75	Observation 1548 1553	capaz
#63	AnnotatorNotes T75	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R45	Overlap Arg1:T74 Arg2:T22	
R46	Overlap Arg1:T75 Arg2:T22	
R47	Used_for Arg1:T26 Arg2:T25	
R48	Causes Arg1:T25 Arg2:T23	
T76	Quantifier_or_Qualifier 1669 1679	limitantes
A1	Status T76 History_of
#64	AnnotatorNotes T76	C0439801; Limited (extensiveness); Functional Concept (?)
R49	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T76	
T77	Observation 1785 1832	presentado alguno de los criterios de exclusión
#65	AnnotatorNotes T77	C3481472; Exclusion criteria present; Finding
R50	Experiences Arg1:T33 Arg2:T8	
T54	Quantifier_or_Qualifier 1116 1131	permanentemente
#47	AnnotatorNotes T54	C0205355; Permanent; Temporal Concept
R10	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T54	
A7	Experiencer T31 Patient
A8	Experiencer T33 Patient
A9	Experiencer T34 Patient
A10	Experiencer T56 Patient
A11	Experiencer T36 Patient
A12	Experiencer T38 Patient
A13	Experiencer T37 Family_member
A14	Experiencer T41 Patient
A15	Experiencer T42 Patient
A16	Assertion T54 Hypothetical
A17	Assertion T13 Hypothetical
